Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ELIZABETH A RAMIREZ DE ARELLANO

Allopathic & Osteopathic Physicians Radiology Diagnostic Radiology

NPI
1235155904
CMS profile
1081536
Location
MIDDLETOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$124,540.00

122 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $124,540.00 122

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $117,630.00 114
PFIZER INC. $6,910.00 8

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ELIZABETH A RAMIREZ DE ARELLANO

NPI 1235155904 · CMS profile ID 1081536

Allopathic & Osteopathic Physicians / Radiology / Diagnostic Radiology

MIDDLETOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1235155904?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ELIZABETH A RAMIREZ DE ARELLANO, NPI 1235155904, CMS profile ID 1081536. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1235155904?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). ELIZABETH A RAMIREZ DE ARELLANO, NPI 1235155904, CMS profile ID 1081536. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1235155904?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
ELIZABETH A RAMIREZ DE ARELLANO, NPI 1235155904, CMS profile ID 1081536, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 122 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1235155904?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

122 matching records · $124,540.00 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 122 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 122.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Merck Sharp & Dohme Corporation $1,620.0008/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747804129 CMS
PFIZER INC. $120.0008/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743616901 CMS
Merck Sharp & Dohme Corporation $900.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747802013 CMS
Merck Sharp & Dohme Corporation $1,140.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747802169 CMS
Merck Sharp & Dohme Corporation $150.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747802561 CMS
Merck Sharp & Dohme Corporation $270.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747802987 CMS
Merck Sharp & Dohme Corporation $270.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747802989 CMS
Merck Sharp & Dohme Corporation $300.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747802995 CMS
Merck Sharp & Dohme Corporation $720.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747803023 CMS
Merck Sharp & Dohme Corporation $3,720.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747803133 CMS
Merck Sharp & Dohme Corporation $600.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747803915 CMS
Merck Sharp & Dohme Corporation $640.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747803917 CMS
Merck Sharp & Dohme Corporation $240.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747804131 CMS
Merck Sharp & Dohme Corporation $740.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747804207 CMS
PFIZER INC. $300.0007/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743617125 CMS
Merck Sharp & Dohme Corporation $1,280.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624259 CMS
Merck Sharp & Dohme Corporation $240.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624319 CMS
Merck Sharp & Dohme Corporation $2,640.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624365 CMS
Merck Sharp & Dohme Corporation $270.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624371 CMS
Merck Sharp & Dohme Corporation $2,700.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624373 CMS
Merck Sharp & Dohme Corporation $420.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624427 CMS
Merck Sharp & Dohme Corporation $60.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624599 CMS
Merck Sharp & Dohme Corporation $80.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624897 CMS
Merck Sharp & Dohme Corporation $1,020.0006/05/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747625221 CMS
Merck Sharp & Dohme Corporation $1,110.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624045 CMS
Merck Sharp & Dohme Corporation $1,440.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624261 CMS
Merck Sharp & Dohme Corporation $3,540.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624379 CMS
Merck Sharp & Dohme Corporation $360.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624423 CMS
Merck Sharp & Dohme Corporation $480.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624449 CMS
Merck Sharp & Dohme Corporation $480.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624451 CMS
Merck Sharp & Dohme Corporation $540.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624561 CMS
Merck Sharp & Dohme Corporation $600.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624601 CMS
Merck Sharp & Dohme Corporation $1,020.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747625219 CMS
PFIZER INC. $840.0005/06/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743631285 CMS
Merck Sharp & Dohme Corporation $120.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624257 CMS
Merck Sharp & Dohme Corporation $150.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624267 CMS
Merck Sharp & Dohme Corporation $1,740.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624269 CMS
Merck Sharp & Dohme Corporation $200.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624313 CMS
Merck Sharp & Dohme Corporation $300.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624375 CMS
Merck Sharp & Dohme Corporation $480.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624429 CMS
Merck Sharp & Dohme Corporation $6,660.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624603 CMS
Merck Sharp & Dohme Corporation $90.0004/08/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624901 CMS
Merck Sharp & Dohme Corporation $3,080.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624083 CMS
Merck Sharp & Dohme Corporation $4,320.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624105 CMS
Merck Sharp & Dohme Corporation $120.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624255 CMS
Merck Sharp & Dohme Corporation $180.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624311 CMS
Merck Sharp & Dohme Corporation $2,040.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624315 CMS
Merck Sharp & Dohme Corporation $2,550.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624321 CMS
Merck Sharp & Dohme Corporation $270.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624369 CMS
Merck Sharp & Dohme Corporation $60.0003/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747624597 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $80,325.00 68
PY2020 $124,540.00 122
PY2021 $91,855.00 123

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $30,975.00 5
PY2024 Recipient $20,730.00 4
PY2023 Recipient $114,720.00 6
PY2022 Recipient $23,490.00 6
PY2021 Recipient $26,325.00 6
PY2020 Recipient $23,850.00 5
PY2019 Recipient $52,560.00 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient E.R. Squibb & Sons, L.L.C. $1,140.00 04/03/2025 Covered Recipient Physician A Phase 3, Open-label, Randomized Study of Nivolumab Combined with Ipilimumab, or with Standard of Care Chemotherapy, versus Standard of Care Chemotherapy in Participants with Previously Untreated Unresectable or Metastatic Urothelial Cancer No dispute reported 06/30/2026 1236002037
Recipient E.R. Squibb & Sons, L.L.C. $3,960.00 04/03/2025 Covered Recipient Physician A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab versus Placebo for Participants with Hepatocellular Carcinoma after Curative Hepatic Resection or Ablation No dispute reported 06/30/2026 1236002041
Recipient E.R. Squibb & Sons, L.L.C. $22,575.00 01/03/2025 Covered Recipient Physician A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS 986205 in Participants with Muscle-Invasive Bladder Cancer No dispute reported 06/30/2026 1236002035
Recipient E.R. Squibb & Sons, L.L.C. $2,520.00 01/03/2025 Covered Recipient Physician A Phase 2 Clinical Trial of Nivolumab, or Nivolumab Combinations in Recurrent and Metastatic Microsatellite Instability High (MSI-H) and Non-MSI-H Colon Cancer No dispute reported 06/30/2026 1236002039
Recipient Eli Lilly and Company $780.00 01/03/2025 Covered Recipient Physician A STUDY OF SELPERCATINIB (LY3527723) IN PARTICIPANTS WITH ADVANCED OR METASTATIC RET FUSION-POSITIVE NON-SMALL CELL LUNG CANCER (LIBRETTO-431) No dispute reported 06/30/2026 1187870973